Maureen Highkin

1.4k total citations
23 papers, 794 citations indexed

About

Maureen Highkin is a scholar working on Oncology, Molecular Biology and Physiology. According to data from OpenAlex, Maureen Highkin has authored 23 papers receiving a total of 794 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 6 papers in Molecular Biology and 6 papers in Physiology. Recurrent topics in Maureen Highkin's work include Cancer Treatment and Pharmacology (3 papers), Animal Virus Infections Studies (3 papers) and Asthma and respiratory diseases (3 papers). Maureen Highkin is often cited by papers focused on Cancer Treatment and Pharmacology (3 papers), Animal Virus Infections Studies (3 papers) and Asthma and respiratory diseases (3 papers). Maureen Highkin collaborates with scholars based in United States, Sweden and Denmark. Maureen Highkin's co-authors include Ehud Lavi, Susan R. Weiss, Thomas P. Misko, Pamela T. Manning, Mark G. Currie, Daniela Salvemini, Amy W. Veenhuizen, Michael Stern, Paul S. Fishman and Donald H. Gilden and has published in prestigious journals such as Science, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Maureen Highkin

23 papers receiving 774 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maureen Highkin United States	14	274	183	163	144	108	23	794
Paul C. Meunier United States	18	303 1.1×	164 0.9×	153 0.9×	68 0.5×	154 1.4×	30	1.2k
David Krause United States	8	368 1.3×	420 2.3×	41 0.3×	67 0.5×	173 1.6×	11	1.0k
Ning‐Na Huang United States	15	635 2.3×	234 1.3×	28 0.2×	94 0.7×	269 2.5×	18	1.3k
Donna Gonzales United States	11	307 1.1×	76 0.4×	25 0.2×	68 0.5×	63 0.6×	21	631
Toshiyuki Hikita Japan	15	443 1.6×	83 0.5×	36 0.2×	140 1.0×	99 0.9×	44	754
Joel Cassel United States	22	772 2.8×	68 0.4×	20 0.1×	168 1.2×	104 1.0×	69	1.3k
Karim Abid Switzerland	15	537 2.0×	72 0.4×	49 0.3×	57 0.4×	63 0.6×	35	1.8k
A.F. Prigent France	14	239 0.9×	116 0.6×	27 0.2×	90 0.6×	62 0.6×	29	590
Maria Ripoli Italy	17	565 2.1×	47 0.3×	18 0.1×	99 0.7×	136 1.3×	23	1.1k
Michael Eder Austria	16	406 1.5×	49 0.3×	16 0.1×	99 0.7×	66 0.6×	59	1.0k

Countries citing papers authored by Maureen Highkin

Since Specialization

Citations

This map shows the geographic impact of Maureen Highkin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Highkin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Highkin more than expected).

Fields of papers citing papers by Maureen Highkin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Highkin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Highkin. The network helps show where Maureen Highkin may publish in the future.

Co-authorship network of co-authors of Maureen Highkin

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Highkin. A scholar is included among the top collaborators of Maureen Highkin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Highkin. Maureen Highkin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Cheng, Xiaoqing, Maureen Highkin, Xiaohua Jin, et al.. (2023). Breast Cancer Mutations HER2V777L and PIK3CAH1047R Activate the p21–CDK4/6–Cyclin D1 Axis to Drive Tumorigenesis and Drug Resistance. Cancer Research. 83(17). 2839–2857. 17 indexed citations

Bose, Ron, Shunqiang Li, Tina Primeau, et al.. (2021). Abstract PS4-13: Irreversible inhibition of HER2 activating mutations with neratinib enhances the pre-clinical efficacy of trastuzumab emtansine and trastuzumab deruxtecan. Cancer Research. 81(4_Supplement). PS4–13. 5 indexed citations

Amin, Manik, Kathryn Trinkaus, Amberly Brown, et al.. (2019). Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer. Journal of Gastrointestinal Oncology. 10(3). 412–420. 7 indexed citations

Jiang, Hongmei, Ming Xu, Lin Li, et al.. (2018). Concurrent HER or PI3K Inhibition Potentiates the Antitumor Effect of the ERK Inhibitor Ulixertinib in Preclinical Pancreatic Cancer Models. Molecular Cancer Therapeutics. 17(10). 2144–2155. 32 indexed citations

Schnute, Mark E., Matthew D. McReynolds, Jill Chrencik, et al.. (2017). Discovery of a Potent and Selective Sphingosine Kinase 1 Inhibitor through the Molecular Combination of Chemotype-Distinct Screening Hits. Journal of Medicinal Chemistry. 60(6). 2562–2572. 38 indexed citations

Amin, Manik, Steven Sorscher, Kian‐Huat Lim, et al.. (2015). Phase II trial of levocetirizine with capecitabine and bevacizumab to overcome the resistance of antiangiogenic therapies in refractory metastatic colorectal cancer.. Journal of Clinical Oncology. 33(3_suppl). 763–763. 1 indexed citations

Misko, Thomas P., Melissa R. Radabaugh, Maureen Highkin, et al.. (2012). Characterization of nitrotyrosine as a biomarker for arthritis and joint injury. Osteoarthritis and Cartilage. 21(1). 151–156. 38 indexed citations

Highkin, Maureen, Matthew Yates, Olga V. Nemirovskiy, et al.. (2011). High-Throughput Screening Assay for Sphingosine Kinase Inhibitors in Whole Blood Using RapidFire® Mass Spectrometry. SLAS DISCOVERY. 16(2). 272–277. 27 indexed citations

Penning, Thomas D., Nizal S. Chandrakumar, B.N. Desai, et al.. (2003). Synthesis of Imidazopyridines and Purines as Potent Inhibitors of Leukotriene A4 Hydrolase. Bioorganic & Medicinal Chemistry Letters. 13(6). 1137–1139. 26 indexed citations

10.

Penning, Thomas D., Nizal S. Chandrakumar, B.N. Desai, et al.. (2002). Pyrrolidine and piperidine analogues of SC-57461A as potent, orally active inhibitors of leukotriene A4 hydrolase. Bioorganic & Medicinal Chemistry Letters. 12(23). 3383–3386. 11 indexed citations

11.

Penning, Thomas D., Mark A. Russell, Helen Y. Chen, et al.. (2002). Synthesis of Potent Leukotriene A₄ Hydrolase Inhibitors. Identification of 3-[Methyl[3-[4-(phenylmethyl)phenoxy]propyl]amino]propanoic Acid. Journal of Medicinal Chemistry. 45(16). 3482–3490. 29 indexed citations

12.

Misko, Thomas P., Maureen Highkin, Amy W. Veenhuizen, et al.. (1998). Characterization of the Cytoprotective Action of Peroxynitrite Decomposition Catalysts. Journal of Biological Chemistry. 273(25). 15646–15653. 211 indexed citations

13.

Hippenmeyer, Paul J. & Maureen Highkin. (1993). High Level, Stable Production of Recombinant Proteins in Mammalian Cell Culture using the Herpesvirus VP16 Transactivator. Nature Biotechnology. 11(9). 1037–1041. 26 indexed citations

14.

Highkin, Maureen, Gwen G. Krivi, & Paul J. Hippenmeyer. (1991). Characterization and Comparison of Avian and Murine Helper Cell Lines for Production of Replication-Defective Retroviruses for Avian Transformation. Poultry Science. 70(4). 970–981. 8 indexed citations

15.

Hippenmeyer, Paul J., Gwen G. Krivi, & Maureen Highkin. (1988). Transfer and expression of the bacterial NPT-II gene In chick embryos using a Schmidt-Ruppin retrovirus vector. Nucleic Acids Research. 16(15). 7619–7632. 15 indexed citations

16.

Lavi, Ehud, Paul S. Fishman, Maureen Highkin, & Susan R. Weiss. (1988). Limbic encephalitis after inhalation of a murine coronavirus.. PubMed. 58(1). 31–6. 79 indexed citations

17.

Lavi, Ehud, Akio Suzumura, Masaaki Hirayama, et al.. (1987). Coronavirus mouse hepatitis virus (MHV)-A59 causes a persistent, productive infection in primary glial cell cultures. Microbial Pathogenesis. 3(2). 79–86. 51 indexed citations

18.

Fishman, Paul S., Jennifer Gass, Peggy Swoveland, et al.. (1985). Infection of the Basal Ganglia by a Murine Coronavirus. Science. 229(4716). 877–879. 61 indexed citations

19.

Lavi, Ehud, Donald H. Gilden, Maureen Highkin, & Susan R. Weiss. (1984). Persistence of mouse hepatitis virus A59 RNA in a slow virus demyelinating infection in mice as detected by in situ hybridization. Journal of Virology. 51(2). 563–566. 83 indexed citations

20.

Lavi, Ehud, Donald H. Gilden, Maureen Highkin, & Susan R. Weiss. (1984). MHV-A59 Pathogenesis in Mice. Advances in experimental medicine and biology. 173. 237–245. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact